Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Iris S.H. Kloots"'
Autor:
Inge M. van Oort, Donjete Simnica, Mascha Binder, Lorenzo F. Fanchi, Iris S.H. Kloots, Edith Willscher, Winald R. Gerritsen, Niven Mehra, Minke Smits
Publikováno v:
JCO Precision Oncology. :1374-1385
PURPOSE Although most patients with microsatellite instable (MSI) metastatic castration-resistant prostate cancer (mCRPC) respond to immune checkpoint blockade (ICB), only a small subset of patients with microsatellite stable (MSS) tumors have simila
Autor:
Samhita Pamidimarri Naga, Inge M. van Oort, Marleen L Duizer, Winald R. Gerritsen, Leonie I. Kroeze, Haiko J. Bloemendal, Malou C.P. Kuppen, Niven Mehra, Jack A. Schalken, Marjolijn J. L. Ligtenberg, Carin A. Uyl-de Groot, Hans M. Westgeest, Iris S.H. Kloots, Peter H.J. Slootbeek, Maarten J. van der Doelen
Publikováno v:
International Journal of Cancer, 148(2), 385-395. Wiley-Liss Inc.
International Journal of Cancer, 148, 385-395
International Journal of Cancer, 148, 2, pp. 385-395
International Journal of Cancer
International Journal of Cancer, 148, 385-395
International Journal of Cancer, 148, 2, pp. 385-395
International Journal of Cancer
Platinum‐based chemotherapy is not standard of care for unselected or genetically selected metastatic castration‐resistant prostate cancer (mCRPC) patients. A retrospective assessment of 71 patients was performed on platinum use in the Netherland
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b79c4ae93d35fe9784f95113f76a3af3
https://pure.eur.nl/en/publications/73fcb740-8fb5-4724-a40b-bf1b43f68133
https://pure.eur.nl/en/publications/73fcb740-8fb5-4724-a40b-bf1b43f68133
Autor:
N. P. van Erp, Harm Westdorp, Linda G W Kerkmeijer, J.A. Schalken, Robert Jan Smeenk, M.H. den Brok, Peter H.J. Slootbeek, J. De Vries, Gosse J. Adema, Mascha Binder, Haiko J. Bloemendal, Niven Mehra, Iris S.H. Kloots, Wim B.M. Gerritsen
Publikováno v:
Annals of Oncology. 32:S671